Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis.

Subjects

Subjects :

Aged
Female
Humans
Biphenyl Compounds adverse effects
Bone Density Conservation Agents adverse effects
Cathepsin K antagonists & inhibitors
Osteoporosis, Postmenopausal drug therapy
Scleroderma, Localized chemically induced
Scleroderma, Systemic chemically induced

Details

Language :

English

ISSN :

1097-6787

Volume :

84

Issue :

4

Database :

MEDLINE

Journal :

Journal of the American Academy of Dermatology

Publication Type :

Academic Journal

Accession number :

32553680

Full Text :

https://doi.org/10.1016/j.jaad.2020.06.036